NEW YORK – Medical research charity LifeArc said on Monday that it is providing £5 million ($6.9 million) in funding to the GenOMICC consortium to support the GenOMICC COVID-19 study.
The consortium, which launched the study in May 2020 in partnership with Genomics England, is using genomics to investigate the genetic factors underlying disease severity and to increase understanding about the disease. The researchers are hoping that they'll be able to compare the genomes of people who had severe illness with those who had more manageable symptoms.